GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: Flotros® | IP-631 | IP631 | Regurin® | Sanctura®
                                 
                                                         
                            
                            
                            
                                 
                                
                                trospium is an approved drug (FDA (2004)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: The marketed product contains trospium chloride (PubChem CID 107979). Note that the INN record for trospium chloride represents a chiral molecule, the closest PubChem match being AC1NR4SW. Our representation and those contained in our links show the non-isomeric molecule.  
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    Trospium is a peripherally restricted muscarinic receptor antagonist.  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| We have been unable to find publicly available bioactivity data for this drug at any of the muscarinic receptor subtypes to substantiate its MMOA, and have therefore not tagged a primary drug target. |